Caring for survivors of childhood cancers: The size of the problem
Introduction
Approximately 70% of children diagnosed with cancer now have long-term survival prospects1 resulting from advances in chemotherapy, paediatric surgery, radiotherapy, supportive care and treatment at specialist paediatric oncology centres with inclusion in clinical trials. The proportion of children referred to the UK’s 22 paediatric oncology centres rose between 1977 and 1984 from 44% to 71%.2 This had a significant impact on survival, particularly for patients with acute lymphoblastic leukaemia, non-Hodgkin’s lymphoma, Ewing’s sarcoma, rhabdomyosarcoma and osteosarcoma.2 Also, the number of patients entered into clinical trials increased. The first national trials for leukaemia began in 1969, and following the formation of the United Kingdom Children’s Cancer Study Group (UKCCSG) in 1977, the number of trials for patients with other types of cancer rose sharply.
Results from the Manchester Children’s Tumour Registry3 and the Northern Region Young Persons’ Malignant Disease Registry4 have demonstrated striking improvements in survival over time, but do not describe the numbers and health status of the survivors.
A previous audit of 290 adult survivors attending our centre for follow-up revealed that chronic medical problems were present in 58% of patients.5 Such problems may not be detected until many years after the completion of treatment.6
This large population-based study examines survival trends for patients diagnosed between 1960 and 1999 in the West Midlands Health Region (population in 2001 5.2 million,7 approximately 9% of the UK population) and describes a current group of long-term survivors (defined as alive 5 years after diagnosis) with respect to their number, characteristics and likely requirement for ongoing medical care.
Section snippets
Methods
The West Midlands Regional Children’s Tumour Registry (WMRCTR) provided data on all children aged 0–14 years, resident in the West Midlands and diagnosed with malignant disease (or a benign brain/central nervous system (CNS) tumour) between 1960 and 1999. Diagnoses were considered to be generally reliable following a pathology review of solid and brain tumour cases diagnosed between 1957 and 1992.8
Trends in survival, for all cancers and specific tumour groups, were examined for four successive
Survival
Survival for all cancers combined improved substantially over the 40-year period (Fig. 1) and 70% (95% confidence interval (CI) 67–72%) of patients diagnosed in 1990–1999 can expect to survive for 5 years or more. Table 1 shows how survival has improved over time for different tumour types.
Survivors
Fig. 2 illustrates the growing number of long-term survivors between 1980 and 2005. The derivation of the number of survivors expected in 2005 is shown in Table 2. The curve for the observed number of
Discussion
During 1960–1999 5022 children resident in the West Midlands were diagnosed with cancer and by 2000 1747 of them were long-term (>5 years) survivors. The actuarial 5-year survival rates rose from 23% (95% CI 20–25%) for those diagnosed in the 1960s to 70% (95% CI 67–72%) for those diagnosed in the 1990s. Consequently, both the proportion of children surviving and their cumulative numbers increased steadily over time.
Based on current incidence and survival data the estimated number of long-term
Conflict of interest statement
None declared.
Acknowledgements
We thank the West Midlands Regional Cancer Registry (now the West Midlands Cancer Intelligence Unit) and the Childhood Cancer Research Group for access to data. We also thank our consultant colleagues and numerous medical records officers, consultants and general practitioners for access to patient records.
This study was supported by the West Midlands Regional Health Authority, the Special Trustees of the Former United Birmingham Hospitals and the Department of Health.
References (27)
- et al.
Endocrine complications of neoplastic diseases in children and adults
Curr Opin Pediatr
(2001) Growth and endocrine function after chemotherapy and radiotherapy in childhood
Eur J Cancer
(2002)- et al.
Developing strategies for long-term follow-up of survivors of childhood cancer
BMJ
(2001) Centralisation of treatment and survival rates for cancer
Arch Dis Child
(1988)- et al.
Improvements in survival from childhood cancer: results of a population based survey over 30 years
BMJ
(1988) - et al.
Incidence and survival for cancer in children and young adults in the North of England, 1968–1995: a report from the Northern Region Young Persons’ Malignant Disease Registry
Br J Cancer
(2000) - et al.
The health status of adult survivors of cancer in childhood
Eur J Cancer
(1988) Long-term survivors of childhood cancer: the late effects of therapy
Oncologist
(1999)- Office for National Statistics. Census 2001. Accessed January 2004. Available from:...
- et al.
The need for specialist review of pathology in paediatric cancer
Br J Cancer
(1997)
Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhood cancer survivor study
J Clin Oncol
Transition to adult health care for adolescents and young adults with cancer
Cancer
Cited by (81)
Doxorubicin-induced cardiotoxicity and risk factors
2024, IJC Heart and VasculaturePrevalence, patterns, and determinants of multimorbidity among childhood and adult cancer survivors: A systematic review.
2023, Critical Reviews in Oncology/HematologyAnthracycline-induced cardiotoxicity — are we about to clear this hurdle?
2023, European Journal of CancerRetrospective estimation of heart and lung doses in pediatric patients treated with spinal irradiation
2018, Radiotherapy and OncologyDoxorubicin induced heart failure: Phenotype and molecular mechanisms
2016, IJC Heart and VasculatureUncovering healthcare practitioners' information processing using the think-aloud method: From paper-based guideline to clinical decision support system
2016, International Journal of Medical Informatics